Exacerbation of graves ophthalmopathy with interferon-α therapy

Ophthalmic Plastic and Reconstructive Surgery

Volumn 23, Issue 4, 2007, Pages 319-321

  DeMartelaere, Sheri L ^a   Green, M Kelly ^b   Shore, John W ^a  

^a Texas Oculoplastic Consultants   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; ENDOCRINE OPHTHALMOPATHY; FAMILY HISTORY; FEMALE; HEPATITIS C; HUMAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; VISUAL ACUITY;

ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; EXOPHTHALMOS; FEMALE; GRAVES OPHTHALMOPATHY; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE I, RECOMBINANT; MIDDLE AGED; RIBAVIRIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34547666811     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/IOP.0b013e3180a72711     Document Type: Article

References (10)

1. Carella C, Mazziotti G, Amato G, et al. Interferon-α-related thyroid disease: pathophysiological, epidemiological, and clinical aspects. J Clin Endocrinol Metabolism 2004;89:3656-61.
2. Binaghi M, Levy C, Douvin C, et al. Severe thyroid ophthalmopathy related to interferon α therapy. J Fr Ophtalmol 2002;25:412-5.
3. Villanueava RB, Brau N. Graves' ophthalmopathy associated with interferon-α treatment for hepatitis C. Thyroid 2002;12:737-8.
4. Su DH, Chang YC, Liao SL, Chang TC. Lanreotide treatment in a patient with interferon-associated Graves' ophthalmopathy. Graefes Arch Clin Exp Ophthalmol 2005;243:269-72.
5. Russo M, Fried M. Side effects of therapy for chronic hepatitis C. Gastroenterology 2003;124:1711-9.
6. Wong V, Fu AX, George J, Cheung NW. Thyrotoxicosis induced by α-interferon therapy in chronic viral hepatitis. Clin Endocrinol 2002;56:793-8.
7. Huet D, Entremont A, Hautecouverture M. Basedow disease and interferon for hepatitis C: recurrence as Basedow ophthalmopathy after interferon reintroduction. Presse Med 2000;29:82.
8. Conlon K, Urba W, Smith J II, et al. Exacerbation of symptoms of autoimmune disease in patients receiving α-interferon therapy. Cancer 1990;65:2237-42.
9. Custro N, Montalto G, Scafidi V, et al. Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy. J Endocrinol Invest 1997;20:374-80.
10. Zignego A, Brechot C. Extrahepatic manifestations of HCV infection: facts and controversies. J Hepatol 1999;31:369-76.